A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia
Clinical trial NCT05326347 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05326347
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-31
- Primary completion
- 2025-08-01
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.